Glaxosmithkline Research & Development Limited payment practices report
PennyFetch rating based on government data:
Good payerCompanies House no. 00835139
This rating is PennyFetch’s own assessment derived from data self-reported by Glaxosmithkline Research & Development Limited to the UK government.
Avg. days to pay
60
UK median: 32
Outside agreed terms
2%
UK average: 24%
Trend
Getting faster
16 reports filed
Payment terms
0 to 60 days
Standard terms
Invoice payment breakdown
How Glaxosmithkline Research & Development Limited compares
Glaxosmithkline Research & Development Limited takes an average of 60 days to pay its suppliers, which is 28 days slower than the UK median of 32 days across 9,336 reporting companies. 2% of their invoices fall outside the agreed payment terms, compared to a national average of 24%. Their payment speed has been improving over time based on historical filings.
The “outside agreed terms” percentage measures how often the company pays after its own agreed payment terms, not against a fixed 30-day standard. A company with long payment terms can still be rated “Good payer” if it consistently meets those terms.
Payment history
| Period | Avg. days | % outside terms | % in 30d | % over 60d |
|---|---|---|---|---|
| Jul 2025 to Dec 2025 | 60 | 2% | 18% | 57% |
| Jan 2025 to Jun 2025 | 60 | 2% | 19% | 57% |
| Jul 2024 to Dec 2024 | 69 | 3% | 13% | 77% |
| Jan 2024 to Jun 2024 | 71 | 4% | 13% | 78% |
| Jul 2023 to Dec 2023 | 68 | 3% | 17% | 74% |
| Jan 2023 to Jun 2023 | 71 | 4% | 15% | 76% |
| Jul 2022 to Dec 2022 | 73 | 3% | 11% | 80% |
| Jan 2022 to Jun 2022 | 73 | 4% | 10% | 81% |
| Jul 2021 to Dec 2021 | 71 | 5% | 15% | 74% |
| Jan 2021 to Jun 2021 | 70 | 4% | 13% | 76% |
| Jul 2020 to Dec 2020 | 65 | 7% | 21% | 69% |
| Jan 2020 to Jun 2020 | 69 | 4% | 14% | 75% |
| Jul 2019 to Dec 2019 | 67 | 5% | 15% | 71% |
| Jan 2019 to Jun 2019 | 70 | 4% | 11% | 75% |
| Jul 2018 to Dec 2018 | 73 | 6% | 9% | 81% |
| Jan 2018 to Jun 2018 | 76 | 13% | 5% | 88% |
PennyFetch tracks your invoices, sends automatic payment reminders, and calculates statutory interest if anything goes overdue.
Get started freeFrequently asked questions
Related tools and guides
All payment statistics on this page are self-reported by Glaxosmithkline Research & Development Limited to the UK Government Payment Practices Reporting service . The government publishes this data but does not independently verify the figures. Published under the Open Government Licence v3.0.
Most recent report filed: Jan 2026. The rating labels on this page (e.g. “Good payer”, “Often outside terms”) are PennyFetch’s own classifications based on the reported data. They are not government ratings. This page is for informational purposes and does not constitute legal or financial advice.
Is this your company?
If you believe this data is incorrect, outdated, or needs additional context, please email corrections@pennyfetch.co.uk. We will review your request and update or add context to this page where appropriate.